Provided by Tiger Trade Technology Pte. Ltd.

Biomerica

2.17
-0.0500-2.25%
Post-market: 2.170.00000.00%16:00 EST
Volume:4.11K
Turnover:9.10K
Market Cap:6.55M
PE:-1.41
High:2.24
Open:2.21
Low:2.17
Close:2.22
52wk High:7.92
52wk Low:2.11
Shares:3.02M
Float Shares:2.94M
Volume Ratio:0.25
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5351
EPS(LYR):-2.1649
ROE:-84.30%
ROA:-49.43%
PB:1.48
PE(LYR):-1.00

Loading ...

Vietnam's Hanoi Department of Health approves Biomerica's EZ Detect for nationwide distribution

Reuters
·
Feb 18

Vietnam Approves Biomerica’s Ez Detect™ for Nationwide Distribution

THOMSON REUTERS
·
Feb 18

Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition

Reuters
·
Jan 15

Biomerica Q2 EPS $(0.45) Up From $(0.48) YoY, Sales $1.210M Down From $1.636M YoY

Benzinga
·
Jan 15

BRIEF-Biomerica Q2 Net Income USD -1.32 Million

Reuters
·
Jan 15

Biomerica Inc. cuts research and development expenses by 27% to USD 0.7 million in second quarter (Q2) fiscal 2026

Reuters
·
Jan 15

Biomerica Q2 Revenue USD 1.21 Million

THOMSON REUTERS
·
Jan 15

Biomerica Q2 Gross Margin 4%

THOMSON REUTERS
·
Jan 15

Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Dow Jones
·
Jan 15

BRIEF-Biomerica Announces CMS Medicare Payment Rate Of $300 For Revolutionary Infoods® IBS Test

Reuters
·
Dec 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary Infoods® Ibs Test

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc - $300 Rate Applies to Medicare Claims From January 2026

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 16, 2025

Egyptian Drug Authority Approves Biomerica's Full Portfolio of Rapid Screening Tests

Reuters
·
Dec 11, 2025

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

GlobeNewswire
·
Nov 25, 2025

BRIEF-Biomerica Expands Contract Development And Manufacturing Services To Meet Growing Market Demand

Reuters
·
Nov 06, 2025

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

GlobeNewswire
·
Nov 06, 2025

Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US

MT Newswires Live
·
Oct 16, 2025

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

GlobeNewswire
·
Oct 16, 2025

Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Reuters
·
Oct 15, 2025